Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains

Virology

Volumn 377, Issue 2, 2008, Pages 296-307

  Vasilakis, Nikos ^a   Fokam, Eric B ^b   Hanson, Christopher T ^c   Weinberg, Ethan ^c   Sall, Amadou A ^d   Whitehead, Stephen S ^c   Hanley, Kathryn A ^e   Weaver, Scott C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF BUEA   (Cameroon)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d INSTITUT PASTEUR DE DAKAR   (Senegal)

^e NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

Dengue virus (DENV); Endemic DENV; Phylogenetic and phenotypic analysis; Sylvatic DENV

Indexed keywords

AMINO ACID; NUCLEOTIDE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENGUE VIRUS; GENE REPLICATION; GENE SEQUENCE; GENETIC TRAIT; GENOME ANALYSIS; GENOTYPE; LIVER CELL; MOLECULAR PHYLOGENY; MORPHOLOGICAL TRAIT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; VIRUS STRAIN;

AEDES; ANIMALS; CELLS, CULTURED; DENGUE; DENGUE VIRUS; GENOME, VIRAL; GENOTYPE; INSECT VECTORS; PHENOTYPE; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP; DENGUE VIRUS TYPE 2; PRIMATES;

EID: 45149135130     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.04.044     Document Type: Article

References (108)

1. Ackermann M., and Padmanabhan R. De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J. Biol. Chem. 276 43 (2001) 39926-39937
2. Armstrong P.M., and Rico-Hesse R. Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am. J. Trop. Med. Hyg. 68 5 (2003) 539-544
3. Blackwell J.L., and Brinton M.A. BHK cell proteins that bind to the 3′ stem-loop structure of the West Nile virus genome RNA. J. Virol. 69 9 (1995) 5650-5658
4. Blackwell J.L., and Brinton M.A. Translation elongation factor-1 alpha interacts with the 3′ stem-loop region of West Nile virus genomic RNA. J. Virol. 71 9 (1997) 6433-6444
5. Bray M., Men R., Tokimatsu I., and Lai C.J. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J. Virol. 72 2 (1998) 1647-1651
6. Brinkworth R.I., Fairlie D.P., Leung D., and Young P.R. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. J. Gen. Virol. 80 Pt 5 (1999) 1167-1177
7. Brinton M.A., Fernandez A.V., and Dispoto J.H. The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology 153 1 (1986) 113-121
8. Carey D.E., Causey O.R., Reddy S., and Cooke A.R. Dengue viruses from febrile patients in Nigeria, 1964-68. Lancet 1 7690 (1971) 105-106
9. Chang G.J., Trent D.W., Vorndam A.V., Vergne E., Kinney R.M., and Mitchell C.J. An integrated target sequence and signal amplification assay, reverse transcriptase-PCR-enzyme-linked immunosorbent assay, to detect and characterize flaviviruses. J. Clin. Microbiol. 32 2 (1994) 477-483
10. Chang C.J., Luh H.W., Wang S.H., Lin H.J., Lee S.C., and Hu S.T. The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein. DNA Cell Biol. 20 9 (2001) 569-577
11. Chen Y., Maguire T., and Marks R.M. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol. 70 12 (1996) 8765-8772
12. Cologna R., and Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77 7 (2003) 3929-3938
13. Cologna R., Armstrong P.M., and Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J. Virol. 79 2 (2005) 853-859
14. Diallo M., Ba Y., Sall A.A., Diop O.M., Ndione J.A., Mondo M., Girault L., and Mathiot C. Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations. Emerg. Infect. Dis. 9 3 (2003) 362-367
15. Diallo M., Sall A.A., Moncayo A.C., Ba Y., Fernandez Z., Ortiz D., Coffey L.L., Mathiot C., Tesh R.B., and Weaver S.C. Potential role of sylvatic and domestic African mosquito species in dengue emergence. Am. J. Trop. Med. Hyg. 73 2 (2005) 445-449
16. Diallo M., Ba Y., Faye O., Soumare M.L., Dia I., and Sall A.A. Vector competence of Aedes aegypti populations from Senegal for sylvatic and epidemic dengue 2 virus isolated in West Africa. Trans. R. Soc. Trop. Med. Hyg. 102 5 (2008) 493-498
17. Domingo E., and Holland J.J. Mutation rates and rapid evolution of RNA viruses. In: Morse S.S. (Ed). Evolutionary Biology of Viruses (1994), Raven Press, New York 161-184
18. Drake J.W., and Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 96 24 (1999) 13910-13913
19. Duarte E.A., Novella I.S., Weaver S.C., Domingo E., Wain-Hobson S., Clarke D.K., Moya A., Elena S.F., de la Torre J.C., and Holland J.J. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 3 4 (1994) 201-214
20. Egloff M.P., Benarroch D., Selisko B., Romette J.L., and Canard B. An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J. 21 11 (2002) 2757-2768
21. Erbel P., Schiering N., D'Arcy A., Renatus M., Kroemer M., Lim S.P., Yin Z., Keller T.H., Vasudevan S.G., and Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 13 4 (2006) 372-373
22. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39 4 (1985) 783-791
23. Gorbalenya A.E., Donchenko A.P., Koonin E.V., and Blinov V.M. N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res. 17 10 (1989) 3889-3897
24. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11 3 (1998) 480-496
25. Hahn C.S., Hahn Y.S., Rice C.M., Lee E., Dalgarno L., Strauss E.G., and Strauss J.H. Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 198 1 (1987) 33-41
26. Halstead S.B. Epidemiology of dengue and dengue hemorrhagic fever. In: Gubler Kuno D.J., and Kuno G. (Eds). Dengue and Dengue Hemorrhagic Fever (1997), CBA international, Oxon, UK
27. Halstead S.B., and O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146 1 (1977) 201-217
28. Halstead S.B., and Palumbo N.E. Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses. Am. J. Trop. Med. Hyg. 22 3 (1973) 375-381
29. Halstead S.B., Casals J., Shotwell H., and Palumbo N. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am. J. Trop. Med. Hyg. 22 3 (1973) 365-374
30. Halstead S.B., Shotwell H., and Casals J. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J. Infect. Dis. 128 1 (1973) 7-14
31. Halstead S.B., Shotwell H., and Casals J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J. Infect. Dis. 128 1 (1973) 15-22
32. Halstead S.B., O'Rourke E.J., and Allison A.C. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J. Exp. Med. 146 1 (1977) 218-229
33. Hanley K.A., Lee J.J., Blaney Jr. J.E., Murphy B.R., and Whitehead S.S. Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes. J. Virol. 76 2 (2002) 525-531
34. Hanley K.A., Manlucu L.R., Manipon G.G., Hanson C.T., Whitehead S.S., Murphy B.R., and Blaney Jr. J.E. Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity. Vaccine 22 25-26 (2004) 3440-3448
35. Hasegawa H., Yoshida M., Shiosaka T., Fujita S., and Kobayashi Y. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191 1 (1992) 158-165
36. Holmes E.C., and Twiddy S.S. The origin, emergence and evolutionary genetics of dengue virus. Infect. Genet. Evol. 3 1 (2003) 19-28
37. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., and Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 78 1 (2004) 378-388
38. Irie K., Mohan P.M., Sasaguri Y., Putnak R., and Padmanabhan R. Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene 75 2 (1989) 197-211
39. Jacobs M.G., Robinson P.J., Bletchly C., Mackenzie J.M., and Young P.R. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 14 11 (2000) 1603-1610
40. Johnson A.J., Guirakhoo F., and Roehrig J.T. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203 2 (1994) 241-249
41. Jones C.T., Ma L., Burgner J.W., Groesch T.D., Post C.B., and Kuhn R.J. Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 77 12 (2003) 7143-7149
42. Jones M., Davidson A., Hibbert L., Gruenwald P., Schlaak J., Ball S., Foster G.R., and Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 79 9 (2005) 5414-5420
43. Khabar K.S., Al-Zoghaibi F., Al-Ahdal M.N., Murayama T., Dhalla M., Mukaida N., Taha M., Al-Sedairy S.T., Siddiqui Y., Kessie G., and Matsushima K. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 186 7 (1997) 1077-1085
44. Khromykh A.A., Meka H., Guyatt K.J., and Westaway E.G. Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 75 14 (2001) 6719-6728
45. Khromykh A.A., Varnavski A.N., Sedlak P.L., and Westaway E.G. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J. Virol. 75 10 (2001) 4633-4640
46. Khromykh A.A., and Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71 2 (1997) 1497-1505
47. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., and Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230 2 (1997) 300-308
48. Kuberski T., Rosen L., Reed D., and Mataika J. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am. J. Trop. Med. Hyg. 26 4 (1977) 775-783
49. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., and Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 5 (2002) 717-725
50. Kummerer B.M., and Rice C.M. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J. Virol. 76 10 (2002) 4773-4784
51. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., de C., Ramos C., and Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73 6 (1999) 4738-4747
52. Leung D., Schroder K., White H., Fang N.X., Stoermer M.J., Abbenante G., Martin J.L., Young P.R., and Fairlie D.P. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 276 49 (2001) 45762-45771
53. Li H., Clum S., You S., Ebner K.E., and Padmanabhan R. The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J. Virol. 73 4 (1999) 3108-3116
54. Ma L., Jones C.T., Groesch T.D., Kuhn R.J., and Post C.B. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. U. S. A. 101 10 (2004) 3414-3419
55. Mandl C.W., Guirakhoo F., Holzmann H., Heinz F.X., and Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 63 2 (1989) 564-571
56. Mandl C.W., Heinz F.X., Puchhammer-Stockl E., and Kunz C. Sequencing the termini of capped viral RNA by 5′-3′ ligation and PCR. Biotechniques 10 4 (1991) 484, 486
57. Marchette N.J., Halstead S.B., Falkler Jr. W.A., Stenhouse A., and Nash D. Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J. Infect. Dis. 128 1 (1973) 23-30
58. Markoff L. 5′- and 3′-noncoding regions in flavivirus RNA. In: Monath T.P., and Chambers T.J. (Eds). The Flaviviruses: Structure, Replication and Evolution. Advances in Virus Research vol. 59 (2003), Elsevier Academic Press, San Diego
59. Mathews D.H., Sabina J., Zuker M., and Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288 5 (1999) 911-940
60. Medin C.L., Fitzgerald K.A., and Rothman A.L. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79 17 (2005) 11053-11061
61. Men R., Bray M., Clark D., Chanock R.M., and Lai C.J. Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J. Virol. 70 6 (1996) 3930-3937
62. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 6972 (2004) 313-319
63. Moncayo A.C., Fernandez Z., Ortiz D., Diallo M., Sall A., Hartman S., Davis C.T., Coffey L., Mathiot C.C., Tesh R.B., and Weaver S.C. Dengue emergence and adaptation to peridomestic mosquitoes. Emerg. Infect. Dis. 10 10 (2004) 1790-1796
64. Munoz-Jordan J.L., Sanchez-Burgos G.G., Laurent-Rolle M., and Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. U. S. A. 100 24 (2003) 14333-14338
65. Munoz-Jordan J.L., Laurent-Rolle M., Ashour J., Martinez-Sobrido L., Ashok M., Lipkin W.I., and Garcia-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79 13 (2005) 8004-8013
66. Niyomrattanakit P., Winoyanuwattikun P., Chanprapaph S., Angsuthanasombat C., Panyim S., and Katzenmeier G. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J. Virol. 78 24 (2004) 13708-13716
67. Nowak T., and Wengler G. Analysis of disulfides present in the membrane proteins of the West Nile flavivirus. Virology 156 1 (1987) 127-137
68. Olsthoorn R.C., and Bol J.F. Sequence comparison and secondary structure analysis of the 3′ noncoding region of flavivirus genomes reveals multiple pseudoknots. Rna 7 10 (2001) 1370-1377
69. Peiris J.S., Dittus W.P., and Ratnayake C.B. Seroepidemiology of dengue and other arboviruses in a natural population of toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka. J. Med. Primatol. 22 4 (1993) 240-245
70. Proutski V., Gould E.A., and Holmes E.C. Secondary structure of the 3′ untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 25 6 (1997) 1194-1202
71. Proutski V., Gritsun T.S., Gould E.A., and Holmes E.C. Biological consequences of deletions within the 3′-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res. 64 2 (1999) 107-123
72. Pryor M.J., Rawlinson S.M., Butcher R.E., Barton C.L., Waterhouse T.A., Vasudevan S.G., Bardin P.G., Wright P.J., Jans D.A., and Davidson A.D. Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection. Traffic 8 7 (2007) 795-807
73. Rauscher S., Flamm C., Mandl C.W., Heinz F.X., and Stadler P.F. Secondary structure of the 3′-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. Rna 3 7 (1997) 779-791
74. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. [see comments]. Nature 375 6529 (1995) 291-298
75. Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L., and Strauss J.H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229 (1985) 726-733
76. Rico-Hesse R. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174 2 (1990) 479-493
77. Rodhain F. The role of monkeys in the biology of dengue and yellow fever. Comp. Immunol. Microbiol. Infect. Dis. 14 1 (1991) 9-19
78. Roehrig J.T., Bolin R.A., and Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246 2 (1998) 317-328
79. Romero T.A., Tumban E., Jun J., Lott W.B., and Hanley K.A. Secondary structure of dengue virus type 4 3′ untranslated region: impact of deletion and substitution mutations. J. Gen. Virol. 87 Pt 11 (2006) 3291-3296
80. Rosen L. Experimental infection of New World monkeys with dengue and yellow fever viruses. Am. J. Trop. Med. Hyg. 7 4 (1958) 406-410
81. Rosen L., and Gubler D. The use of mosquitoes to detect and propagate dengue viruses. Am. J. Trop. Med. Hyg. 23 6 (1974) 1153-1160
82. Rudnick A., and Lim T.W. Dengue fever studies in Malaysia. Inst. Med. Res. Malays. Bull. 23 (1986) 51-152
83. Sabin A.B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1 1 (1952) 30-50
84. Saluzzo J.F., Cornet M., Adam C., Eyraud M., and Digoutte J.P. Dengue 2 in eastern Senegal: serologic survey in simian and human populations. 1974-85. Bull. Soc. Pathol. Exot. Filiales 79 3 (1986) 313-322
85. Saluzzo J.F., Cornet M., Castagnet P., Rey C., and Digoutte J.P. Isolation of dengue 2 and dengue 4 viruses from patients in Senegal. Trans. R. Soc. Trop. Med. Hyg. 80 1 (1986) 5
86. Sanchez I.J., and Ruiz B.H. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J. Gen. Virol. 77 Pt 10 (1996) 2541-2545
87. Scherer W.F., Russell P.K., Rosen L., Casals J., and Dickerman R.W. Experimental infection of chimpanzees with dengue viruses. Am. J. Trop. Med. Hyg. 27 3 (1978) 590-599
88. Shurtleff A.C., Beasley D.W., Chen J.J., Ni H., Suderman M.T., Wang H., Xu R., Wang E., Weaver S.C., Watts D.M., Russell K.L., and Barrett A.D. Genetic variation in the 3′ non-coding region of dengue viruses. Virology 281 1 (2001) 75-87
89. Silva P.A., Molenkamp R., Dalebout T.J., Charlier N., Neyts J.H., Spaan W.J., and Bredenbeek P.J. Conservation of the pentanucleotide motif at the top of the yellow fever virus 17D 3′ stem-loop structure is not required for replication. J. Gen. Virol. 88 Pt 6 (2007) 1738-1747
90. Sirigulpanit W., Kinney R.M., and Leardkamolkarn V. Substitution or deletion mutations between nt 54 and 70 in the 5′ non-coding region of dengue type 2 virus produce variable effects on virus viability. J. Gen. Virol. 88 Pt 6 (2007) 1748-1752
91. Ta M., and Vrati S. Mov34 protein from mouse brain interacts with the 3′ noncoding region of Japanese encephalitis virus. J. Virol. 74 11 (2000) 5108-5115
92. Tajima S., Nukui Y., Takasaki T., and Kurane I. Characterization of the variable region in the 3′ non-translated region of dengue type 1 virus. J. Gen. Virol. 88 Pt 8 (2007) 2214-2222
93. Thurner C., Witwer C., Hofacker I.L., and Stadler P.F. Conserved RNA secondary structures in Flaviviridae genomes. J. Gen. Virol. 85 Pt 5 (2004) 1113-1124
94. Trent D.W. Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing. J. Virol. 22 3 (1977) 608-618
95. Twiddy S.S., Farrar J.J., Vinh Chau N., Wills B., Gould E.A., Gritsun T., Lloyd G., and Holmes E.C. Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology 298 1 (2002) 63-72
96. Twiddy S.S., Woelk C.H., and Holmes E.C. Phylogenetic evidence for adaptive evolution of dengue viruses in nature. J. Gen. Virol. 83 Pt 7 (2002) 1679-1689
97. Uchil P.D., Kumar A.V., and Satchidanandam V. Nuclear localization of flavivirus RNA synthesis in infected cells. J. Virol. 80 11 (2006) 5451-5464
98. Vasilakis N., Holmes E.C., Fokuyam E.B., Faye O., Diallo M., Sall A.A., and Weaver S.C. Evolutionary processes among sylvatic Dengue-2 viruses. J. Virol. 81 (2007) 9591-9595
99. Vasilakis N., Shell E.J., Fokam E.B., Mason P.W., Hanley K.A., Estes D.M., and Weaver S.C. Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology 358 2 (2007) 402-412
100. Vasilakis N., Tesh R.B., and Weaver S.C. Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg. Infect. Dis. 14 3 (2008) 502-504
101. Vasilakis, N., Durbin, A., Travassos da Rosa, A.P.A., Munoz-Jordan, J.L., Tesh, R.B., Weaver, S.C., in press. Antigenic relationships between sylvatic and endemic dengue viruses. Am J. Trop. Med. Hygs.
102. Wang E., Ni H., Xu R., Barrett A.D., Watowich S.J., Gubler D.J., and Weaver S.C. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J. Virol. 74 7 (2000) 3227-3234
103. Wengler G. Terminal sequences of the genome and replicative-form RNA of the flavivirus West Nile virus: absence of poly(A) and possible role in RNA replication. Virology 113 2 (1981) 544-555
104. Whitehead S.S., Blaney J.E., Durbin A.P., and Murphy B.R. Prospects for a dengue virus vaccine. Nat. Rev., Microbiol. 5 7 (2007) 518-528
105. Winkler G., Maxwell S.E., Ruemmler C., and Stollar V. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171 1 (1989) 302-305
106. You S., and Padmanabhan R. A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3′-end of exogenous viral RNA templates requires 5′- and 3′-terminal complementary sequence motifs of the viral RNA. J. Biol. Chem. 274 47 (1999) 33714-33722
107. Zeller H.G., Traore-Lamizana M., Monlun E., Hervy J.P., Mondo M., and Digoutte J.P. Dengue-2 virus isolation from humans during an epizootic in southeastern Senegal in November, 1990. Res. Virol. 143 2 (1992) 101-102
108. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 13 (2003) 3406-3415